This project focuses on understanding the role of the β1 subunit in cardiac electrophysiology and its effect on the pharmacodynamics of antiarrhythmic drugs on the closely associated Na v 1.5 driven sodium current. Voltage-gated ion channels are crucial in regulating cardiac action potentials and maintaining proper heart rhythms. Mutations in the sodium voltage-gated channel beta subunit 1 (SCN1B) gene, which encodes the β1 protein, are associated with various cardiac rhythm disorders. This study aims to explore how the absence of the β1 subunit (via a SCN1B knockout model) alters the cellular response to antiarrhythmic drugs. Results suggest that β1 deletion leads to unexpected changes in action potential duration and QT intervals when under drug perturbation, indicating a regulating interaction between β1 and the sodium late current. Additionally planar patching indicates a differential effect between the WTc and SCN1B KO lines, indicating that the presence of SCN1B is critical to the therapeutic effects of lidocaine. Our findings could contribute to better therapeutic strategies for treating cardiac arrhythmias and improve our understanding of the molecular basis of drug interactions with ion channels.
Marquez et al. (Sun,) studied this question.